Physician profile
Christopher N Eswar
NPI 1598907008
$24,618.09
in general payments reported to CMS, 2019-2025
11 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2021: $271 · 2022: $91.64 · 2023: $64.05 · 2024: $211 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Consulting Fee: $7,650 · Travel and Lodging: $3,087 · Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Consulting Fee | $7,650.00 |
| Travel and Lodging | $3,086.64 |
| Food and Beverage | $1,402.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,211.31 | 2024-2025 | |
| Arthrex, INC. | $8,654.98 | 2025 | |
| Coopersurgical, INC. | $187.43 | 2021-2024 | Supercut Hysterectomy Scissors, Paragard T 380a |
| Abbvie INC. | $172.15 | 2019-2025 | |
| Mimedx Group, INC. | $167.00 | 2024 | |
| Myovant Sciences INC. | $77.61 | 2021-2022 | |
| Pfizer INC. | $53.34 | 2021-2022 | |
| Medtronic, INC. | $33.49 | 2023 | Truclear |
| Organon LLC | $22.09 | 2021 | |
| Hologic Sales and Service, LLC | $19.96 | 2022 | |
| Merck Sharp & Dohme LLC | $18.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Eswar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.